Saved in:
| Main Authors: | Kathleen R. Ruddiman, Jessica K. Bartfield, Irl B. Hirsch |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | https://onlinelibrary.wiley.com/doi/10.1002/oby.70033 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Prevalence of Therapeutic Inertia in the Management of Overweight and Obesity in Patients With a Diagnosis of Type 2 Diabetes Who Are Followed up by Primary Care Physicians
by: Pablo Aschner, et al.
Published: (2026)
by: Pablo Aschner, et al.
Published: (2026)
Use of continuous glucose monitoring when initiating glucagon‐like peptide ‐ 1 receptor agonist therapy in insulin‐treated diabetes
by: Irl B. Hirsch, et al.
Published: (2024)
by: Irl B. Hirsch, et al.
Published: (2024)
Semaglutide vs. Bariatric Surgery: Comparing Costs and Clinical Outcomes in Patients With Diabetes and Obesity
by: Karan R. Chhabra, et al.
Published: (2026)
by: Karan R. Chhabra, et al.
Published: (2026)
Prevalence of Clinical Obesity in US Adults, 2017–2020
by: Yun Shen, et al.
Published: (2025)
by: Yun Shen, et al.
Published: (2025)
Redlining and Prevalent Obesity, Hypertension, and Diabetes in GuLF Study Participants
by: Marina R. Sweeney, et al.
Published: (2026)
by: Marina R. Sweeney, et al.
Published: (2026)
Bridging dose of U‐100 glargine with first dose of insulin degludec improves glycaemia in the 48 h after transition in twice‐daily glargine users
by: Arthi Thirumalai, et al.
Published: (2024)
by: Arthi Thirumalai, et al.
Published: (2024)
Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real‐world analysis
by: Satish K. Garg, et al.
Published: (2024)
by: Satish K. Garg, et al.
Published: (2024)
Application of the Lancet Commission Criteria for the Diagnosis of Obesity to a Clinical Trials Population: The LEAP Trial
by: Faith Anne N. Heeren, et al.
Published: (2025)
by: Faith Anne N. Heeren, et al.
Published: (2025)
Beyond GLP ‐1 Monotherapy: Novel Multi‐Agonists, Amylin Analogues, and Combination Strategies in Obesity and Type 2 Diabetes
by: Mikhail Khachaturov, et al.
Published: (2026)
by: Mikhail Khachaturov, et al.
Published: (2026)
Diabetes, Obesity and Metabolism
Published: (2025)
Published: (2025)
Diabetes, Obesity and Metabolism
Published: (2025)
Published: (2025)
Diabetes, Obesity and Metabolism
Published: (2025)
Published: (2025)
Diabetes, Obesity and Metabolism
Published: (2025)
Published: (2025)
Diabetes, Obesity and Metabolism
Published: (2025)
Published: (2025)
Diabetes, Obesity and Metabolism
Published: (2025)
Published: (2025)
Diabetes, Obesity and Metabolism
Published: (2025)
Published: (2025)
Diabetes, Obesity and Metabolism
Published: (2025)
Published: (2025)
Diabetes, Obesity and Metabolism
Published: (2026)
Published: (2026)
Diabetes, Obesity and Metabolism
Published: (2024)
Published: (2024)
Diabetes, Obesity and Metabolism
Published: (2024)
Published: (2024)
Diabetes, Obesity and Metabolism
Published: (2024)
Published: (2024)
Diabetes, Obesity and Metabolism
Published: (2024)
Published: (2024)
Diabetes, Obesity and Metabolism
Published: (2024)
Published: (2024)
Diabetes, Obesity and Metabolism
Published: (2024)
Published: (2024)
Diabetes, Obesity and Metabolism
Published: (2024)
Published: (2024)
Diabetes, Obesity and Metabolism
Published: (2024)
Published: (2024)
Diabetes, Obesity and Metabolism
Published: (2026)
Published: (2026)
Diabetes, Obesity and Metabolism
Published: (2024)
Published: (2024)
Diabetes, Obesity and Metabolism
Published: (2026)
Published: (2026)
Weight Loss With SGLT2 Inhibitors, Semaglutide, and Transcranial Magnetic Stimulation in Type 2 Diabetes and Obesity
by: Anna Ferrulli, et al.
Published: (2025)
by: Anna Ferrulli, et al.
Published: (2025)
Obesity Prevalence Among U.S. Adults With and Without Disabilities
by: Cheryl D. Fryar, et al.
Published: (2026)
by: Cheryl D. Fryar, et al.
Published: (2026)
GLP‐1 Receptor Agonist Medications for Obesity and Type 2 Diabetes Treatment: A Rapid Review of Changes in Eating Behaviors and Eating Disorder Risk
by: Hiba Jebeile, et al.
Published: (2025)
by: Hiba Jebeile, et al.
Published: (2025)
Clinical Outcomes in the Patient With Traumatic Brain Injury and Comorbid Obesity: A Scoping Review
by: Shawn R. Eagle, et al.
Published: (2025)
by: Shawn R. Eagle, et al.
Published: (2025)
Effects of a 2‐Year Primary Care Weight Loss Intervention on Quality of Life in Patients With Obesity
by: Kara D. Denstel, et al.
Published: (2026)
by: Kara D. Denstel, et al.
Published: (2026)
Metabolic Outcomes in Patients With Type 2 Diabetes Prescribed Incretin‐Based Therapy and Referred or Not to a Weight Management Clinic: A Single‐Center Retrospective Analyses
by: Kathleen M. Robinson, et al.
Published: (2026)
by: Kathleen M. Robinson, et al.
Published: (2026)
Toward Personalized Medicine in Type 1 Diabetes: Understanding How Patient Heterogeneity Influences Therapeutic Efficacy
by: Jasmine Pipella, et al.
Published: (2026)
by: Jasmine Pipella, et al.
Published: (2026)
The Burden of Obesity and Type 1 Diabetes: Distinct and Synergistic Effects to Worsen Perceived Health and Psychosocial Distress
by: Renata Risi, et al.
Published: (2026)
by: Renata Risi, et al.
Published: (2026)
Teplizumab in Stage 2 Type 1 Diabetes: Clinical Practice Experience on Feasibility in 3 Adult Patients
by: V. Guarnotta, et al.
Published: (2026)
by: V. Guarnotta, et al.
Published: (2026)
Beyond BMI : Reassessing the Prevalence of Obesity in Patients With MASLD Under the Lancet Commission Diagnostic Criteria
by: Ru‐Tao Lin, et al.
Published: (2026)
by: Ru‐Tao Lin, et al.
Published: (2026)
Economic Evaluation of the Metabolic and Bariatric Surgery Initiative for Patients With Obesity and Comorbid Diabetes in Queensland
by: Paul Scuffham, et al.
Published: (2026)
by: Paul Scuffham, et al.
Published: (2026)
Similar Items
-
Prevalence of Therapeutic Inertia in the Management of Overweight and Obesity in Patients With a Diagnosis of Type 2 Diabetes Who Are Followed up by Primary Care Physicians
by: Pablo Aschner, et al.
Published: (2026) -
Use of continuous glucose monitoring when initiating glucagon‐like peptide ‐ 1 receptor agonist therapy in insulin‐treated diabetes
by: Irl B. Hirsch, et al.
Published: (2024) -
Semaglutide vs. Bariatric Surgery: Comparing Costs and Clinical Outcomes in Patients With Diabetes and Obesity
by: Karan R. Chhabra, et al.
Published: (2026) -
Prevalence of Clinical Obesity in US Adults, 2017–2020
by: Yun Shen, et al.
Published: (2025) -
Redlining and Prevalent Obesity, Hypertension, and Diabetes in GuLF Study Participants
by: Marina R. Sweeney, et al.
Published: (2026)